Data collected on accrual to two Georgia CORE sponsored Breast Cancer Trials revealed that the cumulative enrollment of minority patients was 55.5%. Accrual of African American patients in community sites was 60% (10 of the 17 patients enrolled) and accrual of all minorities (African American, Asian and Hispanic) in academic affiliate sites (Grady and Winship) was 55%.The successful recruitment of minority patients in clinical trials is an issue of concern as studies report that minority participation is declining (Evelyn and colleagues, 2001) and minority populations are less like to participate in and be offered a clinical trial (American College of Surgeons, 2004).